Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on Linkedin:
“ABO typing is not the same in infants and adults.
And misunderstanding this can affect patient safety.
Many people assume blood grouping works the same way at every age.
In reality, biology changes the interpretation.
This visual highlights one of the most important – and often overlooked — principles in transfusion medicine:
Newborns are not small adults.
In infants:
- Only forward grouping is reliable
- Reverse grouping is often weak or absent
- Detected antibodies are usually maternal IgG
- A and B antigens may be not fully expressed yet
- Testing is often performed to investigate ABO incompatibility in neonatal jaundice
In adults:
- Both forward and reverse grouping are required
- Naturally occurring anti-A and anti-B antibodies are present
- Antigen expression is fully developed
- Results are usually strong and concordant
Understanding this difference prevents:
- misinterpretation of results
- incorrect transfusion decisions
- avoidable neonatal risk
Because safe transfusion practice begins with one principle:
Interpret the test in the context of the patient’s age.
Right test.
Right time.
Right interpretation.
Better outcomes.
Signature of Blood Doki
Educate. Empower. Elevate.”

Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications